Form 4 for CUE Cue Biopharma, Inc.
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-23 · accession 0001209191-23-021201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-27 | 2023-03-23 | CUE | Kiener Peter A | Dir | M - OptEx | $2.86 | +9,682 | 9,682 | New | +$27.7K |
| D | 2023-03-27 | 2023-03-23 | CUE | Kiener Peter A | Dir | S - Sale+OE | $3.28 | -9,325 | 357 | -96% | -$30.6K |
| D | 2023-03-27 | 2023-03-23 | CUE | Kiener Peter A | Dir | M - OptEx | $0.00 | -9,682 | 96.1K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-23 | M | A | 9,682 | $2.86 | 9,682 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-23 | S | D | 9,325 | $3.28 | 357 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-23 | M | D | 9,682 | $0.00 | 96,062 | D | $2.86 · — to 2023-03-23 | 9,682 Common Stock | (F3) This Stock Option became exercisable in five equal annual installments beginning March 23, 2017 and is fully vested. This stock option expired on March 23, 2023. |